We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Tissue

Detectable

Cell line

Detectable

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
HNRNPM
  • premium

    TISSUE

  • premium

    CELL

  • CANCER

ANTIBODY INFORMATION VALIDATION SUMMARY IMMUNOCYTOCHEMISTRY IMMUNOHISTOCHEMISTRY WESTERN BLOT PROTEIN ARRAY ANTIGEN INFORMATION RELEVANT PUBLICATIONS

ANTIBODY INFORMATION

 
 

Antibody HPA024344

 

Antibody CAB016113

 

Provider

Atlas Antibodies
Sigma-Aldrich
  Santa Cruz Biotechnology
 

Product name

HPA024344   sc-20002  

Host species

Rabbit   Mouse  

Clonality

pAb   mAb  

Purity

Affinity purified using the PrEST-antigen as affinity ligand   Protein A/G  

Other gene match

   

Released in version

5   4  

References

1    

VALIDATION SUMMARY

 
 

Antibody HPA024344

 

Antibody CAB016113

 
Immunocytochemistry


Validated
  Approved  
Immunohistochemistry

Supported   Supported  
Western blot


Validated
  Supported  
Protein array

Supported    

IMMUNOCYTOCHEMISTRY

 
 

Antibody HPA024344

 

Antibody CAB016113

 

Formal validation: Genetic

Validated

Significant downregulation > 25% by both siRNA:s.
   

 

Relative fluorescence intensity (RFI)

   

Figure description

Nuclear region of segmented cells in 10x-images    

Antibody dilution

1:28    
 

Standard validation

Approved   Approved  

   

Figure description

Immunofluorescent staining of human cell line A-431 shows localization to nucleoplasm.   Immunofluorescent staining of human cell line U-2 OS shows localization to nucleoplasm.  

Antibody dilution

1:20   1:2000  

Literature conformity

The subcellular location is partly supported by literature or no literature is available.   The subcellular location is partly supported by literature or no literature is available.  

IMMUNOHISTOCHEMISTRY

 
 

Antibody HPA024344

 

Antibody CAB016113

 

Standard validation

Supported   Supported  

   

Figure description

Immunohistochemical staining of human pancreas shows strong nuclear positivity.   Immunohistochemical staining of human pancreas shows strong nuclear positivity.  

Expression

RNA: detected in 37 tissues
Protein: detected in 78 cell types
  RNA: detected in 37 tissues
Protein: detected in 73 cell types
 

Retrieval

HIER pH6   HIER pH6  

Antibody dilution

1:800   1:3500  

Literature conformity

Consistent with extensive gene/protein characterization data.   Consistent with extensive gene/protein characterization data.  

RNA consistency

Mainly consistent with RNA expression data.   Mainly consistent with RNA expression data.  

WESTERN BLOT

 
 

Antibody HPA024344

 

Antibody CAB016113

 

Formal validation: Genetic

Validated

Downregulation visible in both siRNA lanes
   

   

Figure description

Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10
Lane 2: siRNA 1
Lane 3: siRNA 2
Lane 4: Scrambled
   

Target mass (kDa)

77.6, 77.5, 73.6, 39.9    

Loading control

Total protein image    

Antibody dilution

1:63    
 

Standard validation

Supported

Analysis performed using a standard panel of samples.
Band of predicted size in kDa (+/-20%) with additional bands present.
  Supported

Analysis performed using a standard panel of samples.
Band of predicted size in kDa (+/-20%) with additional bands present.
 

   

Figure description

Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11
Lane 2: RT4
Lane 3: U-251 MG
Lane 4: Human Plasma
Lane 5: Liver
Lane 6: Tonsil
  Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 11
Lane 2: RT4
Lane 3: U-251 MG
Lane 4: Human Plasma
Lane 5: Liver
Lane 6: Tonsil
 

Target mass (kDa)

77.6, 77.5, 73.6, 39.9   77.6, 77.5, 73.6, 39.9, 38.2, 37.7, 30.1, 24.1, 22.6, 12.3, 10  

Antibody dilution

1:250   1:500  

PROTEIN ARRAY

 
 

Antibody HPA024344

 

Antibody CAB016113

 

Standard validation

Supported

Pass with single peak corresponding to interaction only with its own antigen.
   

   

Figure description

Antibody specificity analysis with protein arrays. Predicted and matching interactions are shown in green.    

Antibody dilution

1:3000    

ANTIGEN INFORMATION

 
 

Antibody HPA024344

 

Antibody CAB016113

 

Antigen

Recombinant protein fragment   Not known  

Length (aa)

105    

Antigen sequence

NKMGGMEGPFGGGMENMGRFGSGMNMGRINEILSNALKRGEIIAKQGGGG
GGGSVPGIERMGPGIDRLGGAGMERMGAGLGHGMDRVGSEIERMGLVMDR
MGSVE
   

Matching transcripts

HNRNPM-001 - ENSP00000325732 [100%]
HNRNPM-002 - ENSP00000325376 [100%]
HNRNPM-201 - ENSP00000483715 [100%]
HNRNPM-007 - ENSP00000470635 [83%]
   

Other gene match

   
ANTIGEN VIEW
HNRNPM-001
HNRNPM-002
HNRNPM-007
HNRNPM-201

RELEVANT PUBLICATIONS

 
 

Antibody HPA024344

 

Antibody CAB016113

 

1.

Magnetic fractionation and proteomic dissection of cellular organelles occupied by the late replication complexes of Semliki Forest virus
Varjak M et al
J Virol 2013;87(18):10295-312
   
 

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.